July 2023 Alpha-Numeric HCPCS File (ZIP) -. , May 28, 2021 /PRNewswire/ -- SOFIE, an established Radiopharmaceutical Contract Manufacturing Organization and GMP radiopharmacy network, will be commercially. CPT Code 78815. 803-296-3100. Your doctor, hospital, or clinic will provide this medication. 00 anymore and it is billing Medicare and secondary insurances for part B. Brain $2,250 – $10,700. Jacksonville, FL 32256. Each milliliter contains 37 to 2,960 MBq (1 to 80 mCi) piflufolastat F 18 with ≤0. An FDA-cleared medical. Pediatric Acute Lymphoblastic Leukemia Version 3. It is very specific to the prostate as very few organs exhibit PSMA. 7 million in the same period last year. Password. Pylarify specifically is a radionuclide tracer. 1007/978-3-642-10853-2_12. Two huge advances have dramatically changed the diagnosis and treatment of metastatic prostate cancer, and both of these involve prostate-specific membrane antigen (PSMA), a molecule that sits on the surface of prostate cancer cells. FDA-Approved Drugs in 2020. The excretory duct of the seminal vesicle unites with the ductus deferens to form the ejaculatory duct . “It has no pharmacological effect; it’s given in trace doses. • Assay the dose in a suitable dose calibrator prior to administration. The biggest one that can be an issue is the salivary glands, but it. PYLARIFY® attaches to prostate-specific membrane antigen (PSMA), a protein found on the surface of most—approximately 95%—prostate cancer cells. Medicare did not pay for the Pylarify used in PSMA PET/CT Scan. Purpose: 18F-fluorodeoxyglucose (FDG) PET/CT is invaluable in managing liver lesions, in particular in the evaluation of suspected liver metastases. National Range: $1,250 – $9,225+. People with Medicare part B and without supplemental insurance will pay 20% of the $ 5224. Claim status, eligibility and financial related questions will be serviced through the Interactive Voice Response Unit (IVR). This means that a negative PYLARIFY PET/CT scan does not rule out that you have prostate cancer, and a positive PYLARIFY PET/CT scan does not confirm that you have prostate cancer. Last updated: August 31, 2023. Easy-access savings: allows withdrawals. Meet with Your MAC: November 30, 2023 Registration Closed Jurisdictions J and M Part B Behavioral Health Initiative Services Overview Webinar: November 30, 2023 Register - 5 Days Left. Follow a low carbohydrate diet for 48 hours. ICD 10 code for Helicobacter pylori [H. Drug Trials Snapshot. S. SANTA BARBARA, Calif. 00 for the Pylarify PET/CT. 9h ago. 9% Sodium Chloride Injection, USP. 11/11/2022. The superficial inguinal lymph nodes drain the anal canal (below the pectinate line), the skin below the umbilicus, lower extremity, scrotum, and vulva. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider. 29, 2021 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. PDF Version. 8 - other international versions of ICD-10 J94. Our wellness center offers a spa-like. For the example of OCN –, there are three non-equivalent resonance structures, depending on how the multiple bonds are formed in Step 6 of the Lewis structure drawing procedure. False positives with [18F]PSMA PET/CT scans (Pylarify) " Background: PET-CT using prostate-specific membrane antigen (PSMA)-targeting radiopharmaceuticals labeled with 68Ga or 18F has emerged as the most sensitive staging tool in prostate cancer (PC). PYLARIFY Injection is designed to detect prostate-specific membrane. Medical Policy Overview & Search. Glendale, AZ 85306. Closed - Open: 7am-5pm. Search by procedure name or. Piflufolastat F-18, sold under the brand name Pylarify among others, is a radioactive diagnostic agent used for positron emission tomography (PET) imaging. 5 million. Take a 360 tour of our Little Miracles maternity unit. Pluvicto is a targeted radioactive therapy. 45M Seed funding. 8 may differ. Introduction: Prostate cancer is the most common cancer and a leading cause of cancer-related deaths in men. and $50,000 in a high-yield savings account. de. The cancer cells appear as big spots in the PET scan. fatigue. Date Published (original date) 2021. The tracer usually is a substance (such as glucose) that can be used (metabolized) by cells in the body. For the positron emission tomography (PET) imaging of prostate cancer, radiotracers targeting the prostate-specific membrane antigen (PSMA) are nowadays used in clinical practice. November 22, 2021 08:30 ET | Source: Lantheus Holdings. Our appointment specialists are ready to help you find what you need. PYLARIFY is a sterile, non-pyrogenic, clear, colorless solution for intravenous injection. TOWER SAINT JOHN’S IMAGING. Pylarify is the largest growth driver for the company as it comprised 65% of total Q1 2023 revenue. finerenone. Stage 2. Santa Monica, CA 90403 Telephone: 310. Drug information provided by: Merative, Micromedex® US Brand Name. 1. PSMA PET scans use a tracer to help pinpoint. ***PSMA PET is available at select GenesisCare sites that provide PET imaging. To qualify for Pluvicto, one needs a positive PSMA PET scan, but. Login. User Name. Inpatient Facility Average: $7,275. 9 mg ethanol in 0. PYLARIFY, approved by the FDA in May 2021, is the first commercially and widely available prostate-specific membrane antigen (PSMA) PET imaging agent. • Assay the dose in a suitable dose calibrator prior to administration. Location website. 7 mi. 60% annual percentage yield (APY. Company Type: Biotechnology. This drug is likely to be covered under your medical benefit if you have insurance. ** PSMA supply subject to availability per location. It is carried out by injection of a radiopharmaceutical with a positron or gamma emitting radionuclide and a prostate-specific membrane antigen (PSMA) targeting ligand. Our medical policies help us determine what technology, procedure, treatment, supply, equipment, drug, or. PYLARIFY ® (piflufolastat F 18) injection (also known as 18 F-DCFPyL or PyL) is a fluorinated small molecule PSMA-targeted PET imaging agent that enables visualization of lymph nodes, bone and. INDICATION. In. Lantheus expects their fully diluted adjusted earnings per share to be between $0. This drug is administered by your healthcare practitioner (HCP), which usually means: It may be expensive. U. However, 68 Ga has several shortcomings as a radiolabel including short half-life and non-ideal energies, and this has motivated consideration of 18 F-labelled analogs. Additionally. To find the most recent Medical Necessity Review list, precertification policies, and modifiers and reimbursement policies. 4083 Introduction: 18F-Pylarify is the first commercially available prostate specific membrane antigen (PMSA) positron emission tomography (PET) imaging agent for prostate cancer. PYLARIFY® uses a radioactive tracer called fluorine-18, or 18. Pylarify approved by NCCN for Pluvicto. , Nov. • Assay the dose in a suitable dose calibrator prior to administration. Compare Prices Specify your dosage and quantity to find out exactly how much you can save. PYLARIFY ® (piflufolastat F 18) injection (also known as 18 F-DCFPyL or PyL) is a fluorinated small molecule PSMA-targeted PET imaging agent that enables visualization of lymph nodes, bone and soft tissue metastases to determine the presence or absence of recurrent and/or metastatic prostatePiflufolastat F 18 (PYLARIFY®) is an 18F-labelled diagnostic imaging agent that has been developed by Progenics Pharmaceuticals Inc. S. Vulvar Cancer Version 2. It is most commonly used for evaluating primary and metastatic well-differentiated neuroendocrine tumors. GFR* 15 mL/min/1. PYLARIFY AI™, FDA-cleared artificial intelligence platform developed to assist in standardized quantification of PSMA PET/CT scans Oral Presentation: Date & Time: June 12, 2022, 3:00 – 4:30 PM PTPYLARIFY AI™ (aPROMISE) is the only deep learning enabled FDA-cleared medical device software to offer standardized PSMA PET reporting with PYLARIFY AI on PSMA PET/CT images, including those. I think Kaiser will allow you to also get an mpMRI, which may prove to be useful if your recurrence is intra-prostatic. , [18F]-DCFPyL was approved by the FDA in May of 2021 and is commercially available as PYLARIFY® (Piflufolastat F 18 Injection) and sold by Lantheus. Squamous Cell Skin Cancer Version 1. 01 µg/mCi of piflufolastat at calibration time and date, and ≤ 78. Ga-68-Dotatoc is a healthcare provider (HCP) administered medication. PyL PET imaging is approved for two types of patients with. Company Stage: Development. • Calculate the necessary volume to administer based on calibration time and required dose. Innovation in Oncology Drug Pricing: A Comparative Study of Savings Potential - Ruchika Talwar & Brian Cortese. Meanwhile, the CT scan uses x-rays to show the organs and tissues. This drug is likely to be covered under your medical benefit if you have insurance. , a Novartis company) for the treatment of. I was previously told that Medicare covered the. with suspected metastasis who are candidates for initial definitive therapy. 6-10 PYLARIFY ® (piflufolastat F. To view your VA Radiology reports you must: Be a Veteran enrolled at a VA health care facility. doi: 10. Search or Select from Dropdown. An amide is an organic functional group with a carbonyl bonded to a nitrogen or any compound containing this functional group. Pylarify PET Scan ($7,900) Ga-68 PSMA Illucix Scan ($7,650) Our Location. Your doctor, hospital, or clinic will provide this medication. “As an innovation driven leader committed to bringing novel radiopharmaceuticals to the healthcare community, we are proud of the positive impact we have made in the lives of more than 1. Welcome to the Lantheus Third Quarter 2023 Financial Results. 9% sodium chloride injection USP. DULLES, Va. Shawbrook Bank – 5. 60%. 117-328), which staved off certain Medicare cuts, CMS updated the CY 2023 conversion factor in January 2023 to $33. com) -- Lantheus Holdings, Inc. Saving $1 million (or more) for retirement is a great goal to have. Prior authorization for care. Additionally, some health plans administered by Cigna Healthcare. , May 28, 2021 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the U. The PYLARIFY® patient brochure includes information on prostate cancer, an overview of how PYLARIFY® can help you and your doctor create an optimal treatment plan, as well. For men with prostate cancer, PYLARIFY PET. Health Canada is responsible for helping Canadians maintain and improve their health. Español. The men in this study had been. Health Policy and Management. Labor & Delivery Suites. The recommended PYLARIFY dose is 333 MBq (9 mCi) with an acceptable range of 296 MBq to 370 MBq (8 mCi to 10 mCi), administered as a bolus intravenous injection. Radiation therapy (radiotherapy) uses high-energy beams to treat cancer. PYLARIFY AI is an FDA-cleared artificial intelligence platform developed to assist in standardized quantification of PSMA PET/CT scans. NORTH BILLERICA, Mass. This medication is widely available without prescription and is present in many of the cold and flu remedies as well as in prescribed pain medications. The Johns. 24, 2022 (GLOBE NEWSWIRE) -- Palette Life Sciences (“Palette”), a global medical device company dedicated to improving prostate radiation. 9% Sodium Chloride Injection USP. Seek medical care or call 911 at once if you have the following serious side effects: Serious eye symptoms such as sudden vision loss, blurred vision, tunnel vision, eye pain or swelling, or seeing halos around lights; Serious heart symptoms such as fast, irregular, or. Specifically, GenesisCare will enable patient access to the PSMA-PET imaging agent piflufolastat F 18 (Pylarify), which the FDA approved in May 2021 for identifying suspected metastasis or. 3-75. 00. Lantheus has also developed an AI-powered cardiac imaging platform called PYLARIFY AI, which uses machine learning algorithms to improve the accuracy of echocardiography diagnoses and reduce the need for invasive diagnostic procedures. This dataset provides data for wholesale acquisition cost (WAC) increases that exceed the statutorily-mandated WAC increase threshold of a 16% increase for the period including the current quarter and the previous two calendar years for prescription drug products with a WAC greater than $40 for a course of therapy. The Department of Health Policy and Management, one of the largest in the country, is dedicated to advancing local, national, and global health policy to make a difference. 220. 9% Sodium Chloride Injection, USP. Use of standardized procedures will increase the applicability of clinical research among multiple institutions, in turn, increasing the value of research studies, particularly. 00 anymore and it is billing Medicare and secondary insurances for part B. PYLARIFY AI™ (aPROMISE) is the only deep learning enabled FDA-cleared medical device software to offer standardized PSMA PET reporting with PYLARIFY AI on PSMA PET/CT images, including those. A pre-treatment Pylarify PET/CT has the potential to change management plans based on conventional imaging. The doctor’s office will process any payments related to your visit and treatment. People with Medicare part B and without supplemental insurance will pay 20% of the $. 75 a week) in a savings account that compounds monthly and earns a 4% annual interest rate, you would save more than $5,000 in three. whose newly diagnosed cancer could be cured with the initial treatment, or. The platform. LOCAMETZ ® (kit for the preparation of gallium Ga 68 gozetotide injection), after radiolabeling with gallium-68, is indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA)-positive lesions in men with prostate cancer: with suspected metastasis who are candidates for initial definitive therapy. by year endNORTH BILLERICA, Mass. PYLARIFY AI is intended to be used by healthcare professionals and researchers for acceptance, transfer, storage, image display, manipulation, quantification and reporting of digital medical images. Magnetic Resonance Angiography (MRA) Computerized Tomography (CT) scans. 72 at the end of last week, then rose to as high. For UCSF patients , please reach out to Radiology Scheduling (415) 353-3900 directly to schedule your PSMA scan. PYLARIFY® CODING AND BILLING GUIDE | PYLARIFY® Reimbursement Hotline: 844-339-8514 PYLARIFY® and the associated services provided in a physician office are billed on the CMS-1500 claim form or its electronic equivalent. •isually inspect the radiopharmaceutical solution. January 2024 Alpha-Numeric HCPCS Files (ZIP) - Updated 11/21/2023. The product's dosage form is injection, and is administered via intravenous form. The U. This drug is administered by your healthcare practitioner (HCP), which usually means: It may be expensive. Tel: (904) 562-4400. About PYLARIFY ® (piflufolastat F 18) Injection PYLARIFY ® (piflufolastat F 18) injection (also known as 18 F-DCFPyL or PyL) is a fluorinated small molecule PSMA-targeted PET imaging agent that enables visualization of lymph nodes, bone and soft tissue metastases to determine the presence or absence of recurrent and/or metastatic prostate. The company only. Reference is also made to your clinical pharmacology response of November 19, statistical response of December 23, clinical response of December 29, 2020, statistical response of The NCCN has added Ga 68– and F 18–based PSMA-PET imaging modalities to its clinical practice guidelines for prostate cancer. Efficacy: High-risk PCa: OSPREY COHORT A; Efficacy: Biochemically Recurrent PCa: CONDOR; Efficacy:. The doctor’s office will process any payments related to your visit and treatment. PYLARIFY ® (piflufolastat F 18) Injection In the U. -1. PYLARIFY will be available immediately to imaging centers in parts of the mid-Atlantic and southern regions and is expected to be broadly available throughout the U. S. Click the link below to view a short video on the Patient Portal. Do not eat foods with more than 5g of carbohydrates per serving, no more than 15g of carbohydrates per meal and no more than 50g of carbohydrates per day. Orgovyx tablets contain 120mg of relugolix and are light red, almond-shaped, film-coated, debossed with “R” on one side. 68. 8 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Morris, MD, discusses the choice between the 2 FDA-approved PSMA-PET imaging agents—and piflufolastat F 18 (18F-DCFPyL; Pylarify) and Gallium 68 PSMA-11 (Ga 68 PSMA-11)—for managing patients with prostate cancer. If you are unsure which exam your doctor has ordered, please call our scheduling department at: 310-423-8000 (option 1). J94. The UW Medicine healthcare system includes UW Medical Center, rated the #1 hospital in Washington by the U. 11/11/2022. S. By targeting PSMA, PYLARIFY® can give your doctor a clear image and additional information on the location and extent of the cancer. This guideline covers advanced prostate cancer, including disease stages that range from prostate-specific antigen (PSA. 9 % $ 621,419 $ 366,763 . 2024. 6% for nine months. Compare our savings account rates to find the best savings account or CD account to reach your future savings goals. Every Type of Cancer, Expertly Treated. Inject a bolus of 9 mCi (333 MBq) of PYLARIFY® with an acceptable range of 296 MBq to 370 MBq (8 mCi to 10 mCi) administered as a single bolus intravenous injection. Your MITS provider will use your medical history and blood test results to decide when to start your Pluvicto treatment. PYLARIFY also has the largest dedicated commercial team and significant adoption as demonstrated by the more than 200,000. Author. For non-UCSF facilities referring patients that are new to UCSF, please fax the following to (415) 353-7299 for patient registration to. Providers must read the entire NCD and related Internet Only Manual (IOM) sections (see "Sources" at end of this article) in order to correctly understand and apply the following coding guidance. PYLARIFY PET/CT with PSMA Tracer. The simplest amides are derivatives of ammonia. Checking accounts. IGH and TP53. Indication. S. It is sometimes an option when prostate cancer returns after treatment with radiation therapy. Our surgeons are also highly experienced in a procedure called salvage radical prostatectomy. Post Administration Instructions • Follow the PYLARIFY injection with an intravenous flush of 0. Prior authorization is a process that requires either your provider or you to obtain approval from Harvard Pilgrim before receiving specific items and services. Medical technology is continuously evolving; our coverage policies are subject to change without prior notice. 2024. This handout explains a PET/CT Pylarify PSMA scan. For any questions, please call 1-877-744-5675 or write: Pfizer Oncology Together Co-Pay Savings Program, 2250 Perimeter Park Drive, Suite 300, Morrisville, NC 27560. For example, shares gapped up 11% in November of last year following the company's quarterly report. I have a $220,000 mortgage. UCLA is not charging the $ 3,300. 9% Sodium Chloride . 1. 45%. treedown in reply to Tall_Allen 10 months ago. Effective 3/1/21 price states other than AK, HI at $359. The pH of the solution is 4. Select appropriate option from main menu to use the IVR or speak with a Customer Service Representative. 88 Billing guidance:Commitments build on earlier efforts to support Medicare Advantage members during public health emergency Today, Humana Inc. S. That’s why Horizon NJ Health has a committee made up of doctors and pharmacists who review and approve our formulary. Password. Received the EOB for my Pylarify PSMA scan. Bridging the Gap Between Medical AI Research and Real-World Clinical Impact. 73 m 2 BSA ( chronic kidney disease Chronic Kidney Disease Chronic kidney disease (CKD) is long-standing, progressive deterioration of renal function. Please read the disclaimer. PSMA-targeting radiotracers, including a small molecule-based agent developed at Johns Hopkins. 3. Pylarify's revenue more than doubled in Q1 2023 over Q1 2022 from $92. 8 became effective on October 1, 2023. The most common side effects reported by females taking NEXTSTELLIS in a study were spotting or bleeding between menstrual periods, mood changes, headache, breast tenderness, pain and discomfort, painful periods, acne, weight gain, and decreased sex drive. Background/aim: We aimed to define the optimal SUV(max) cut-off value in determination of mediastinal-hilar lymph node metastasis, by comparing positive PET/CT results with the results of endobronchial ultrasound guided transbronchial needle aspiration biopsy (EBUS-TBNA). 9% sodium chloride injection USP. Breast MRI. Cancer of the ureter (ureteral cancer) is an abnormal growth of cells on the inside lining of the tubes (ureters) that connect your kidneys to your bladder. Take a 360 tour of our labor & delivery suites. (NASDAQ:LNTH) Q3 2023 Earnings Call Transcript November 3, 2023 Operator: Good morning. Sibley Hospital is recognized for excellence in many medical specialties, attracting top doctors in all departments. The management of advanced prostate cancer is rapidly evolving. Ultrasound. HCP administered medications are sold and given to you by your physician. Jordan, Radiopharmaceutical Production Technologist. This drug is administered by your healthcare practitioner (HCP), which usually means: It may be expensive. GenesisCare is expanding access to PSMA-PET imaging to all of its US sites by mid-2022, according to a news release from the oncology provider. Discuss your imaging options with your Referring Physician, or feel free to call us here at ADR if you have any questions about our services. Frederic Pouliot, Hospitalier Universitaire (CHU) de Québec-Université Laval. You can renew prescriptions, send messages, and schedule appointments – all. 1007/s00261-013-0043-3. IMG 5012. PYLARIFY® (piflufolastat F 18) Injection is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer: with suspected metastasis who are candidates for initial definitive therapy. 00 - *Effective 10/1/17 AK price at $400, HI $551. PYLARIFY® FOR PCa IMAGING; EFFICACY AND SAFETY. Doctors use nuclear medicine to diagnose, evaluate, and treat various diseases. TRICARE covers the following when medically necessary: Magnetic Resonance Imaging (MRI) with or without contrast media. [1] [4] [5] It is. If your doctor wants to prescribe a drug that is not. The deep inguinal lymph nodes are within the femoral sheath medial to the femoral vein. You cannot fill this prescription in a regular pharmacy. Therapy with Proleukin ® (aldesleukin) should be restricted to patients with normal cardiac and pulmonary functions as defined by thallium stress testingDrug Trials Snapshots: breaking down the what, how and why. May 27, 2021 — Today, the FDA approved the 18F-DCFPyL PSMA PET imaging agent (also known as “PyL” for short or by its trade name “PYLARIFY”). Phone numbers must be entered on all dose orders. 9% Sodium Chloride Injection USP. Clinical Application And Utility Of PYLARIFY. The performance of PYLARIFY for imaging of patients with biochemical evidence of recurrence of prostate cancer seems to be affected by serum PSA levels. It tells how the scan works, how to prepare, what to expect, and how to get your results. LRC-0823. uni-rostock. Checking accounts. We’ve made it easy to start selling with Payify. High-yield savings accounts. Show coupon to your pharmacist Present your printed or electronic coupon when you pick up your prescription. • PYLARIFY seems to be affected by the amount (level) of PSA in your blood. Our. This includes patches. In some cases, depending on the clinical scenario, the same diagnosis code describes a. PYLARIFY® FOR PCa IMAGING; EFFICACY AND SAFETY. PLUVICTO dosing schedule2. Here you will find information for assessing coverage options, guidelines for clinical utilization management, practice policies, the provider manual and support for delivering benefits to our members. It targets a. Saving $1 million (or more) for retirement is a great goal to have. 50. Additionally, there is some overlap with prebiopsy. who have been treated. The approved prescription drugs that Horizon NJ Health covers make up our formulary. Next came sodium fluoride (NaF), which. PYLARIFY AI™ Indications for Use PYLARIFY AI is intended to be used by healthcare professionals and researchers for acceptance, transfer, storage, image display, manipulation, quantification and reporting of digital medical images. 45%. PYLARIFY ® (Piflufolastat F18. Lantheus presented study results providing independent validation of PYLARIFY AI™, the Compan. Find your nearest center to order PYLARIFY® for PET/CT scans, as well as downloadable resources and reimbursement support inf. PYLARIFY ® (piflufolastat F 18) Injection is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer: with suspected metastasis who are candidates for initial definitive therapy. 20 for the third quarter 2021, compared to GAAP fully diluted net. -1. PETNET Solutions Inc, A Siemens Healthineers Company, reliably delivers PET radiopharmaceuticals via the largest network of cyclotron-equipped radiopharmacies globally. 4 GBq (200 mCi) of radioactivity at the date and time of administration. Strong CYP3A Inducers . Monument Bank – 5. Read more. S. 3e Three non. Make sure they know all the medications you’re taking. SoFi members with Direct Deposit or $5,000 or more in Qualifying Deposits during the 30-Day Evaluation Period can earn 4. Checking accounts. In addition to clinical drug information, FDB publishes several drug pricing data fields, including: FDB discontinued the publication of Blue Book Average Wholesale Price (AWP) on September. It is very specific to the prostate as very few organs exhibit PSMA. 91% for one year. 8 million, compared to a loss of $21. Tauvid. PYLARIFY is a radioactive drug, which will increase lifetime radiation exposure. Abdominal pain Dizziness including absent forelimb(s), absent hindpaw, absent ear pinna, and thoracogastroschisis at dose exposures greater or equal to approximately 5 times the human exposure at the recommendedAbstract. PYLARIFY may be diluted with 0. 10261 Twin Lake Loop, Dripping Springs, Texas 78620, US. Key takeaways. There’s obviously Pylarify [piflufolastat]. The stock closed at $59. Patient Portal Video. If you are considering a PSMA PET scan, please discuss with. “PYLARIFY has the potential to contribute meaningful and actionable information that can be used to personalize treatment plans in men with low PSA levels,” said Dr. • PYLARIFY seems to be affected by the amount (level) of PSA in your blood.